A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

Phase 4 Unknown 1000 enrolled Eyetech Pharmaceuticals Pfizer · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to explore the safety and efficacy of Macugen given as maintenance therapy in patients who have had initial success with another AMD treatment. Patients must have 1, but not more than 3 prior treatments for Neovascular AMD.

Timeline

Start: 2006-06
Primary completion: —
Completion: —

Publications

Friberg TR, Tolentino M; LEVEL Study Group; Weber P, Patel S, Campbell S, Goldbaum M. Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. Br J Ophthalmol. 2010 Dec;94(12):1611-7. doi: 10.1136/bjo.2009.174946. Epub 2010 May 14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	pegaptanib sodium	Aptamer	0.3 mg	Intravitreal

A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

Summary

Timeline

Publications

Drugs

Indications